+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pancreatic Cancer"

From
Oncology Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2019-2024

  • Report
  • October 2024
  • 1800 Pages
  • Global
From
From
Global Cancer Cachexia Market Report 2024 - Product Thumbnail Image

Global Cancer Cachexia Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Generic Oncology Sterile Injectable Market Report 2025 - Product Thumbnail Image

Generic Oncology Sterile Injectable Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Oncology Nutrition Market Report 2025 - Product Thumbnail Image

Oncology Nutrition Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Community Oncology Services Market Report 2025 - Product Thumbnail Image

Community Oncology Services Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • March 2025
  • 88 Pages
  • Global
From
Cancer Cachexia Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cancer Cachexia Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 145 Pages
  • Global
From
From
From
From
From
Loading Indicator

Pancreatic cancer is a type of cancer that affects the pancreas, an organ located in the abdomen. It is one of the most aggressive and deadly forms of cancer, with a five-year survival rate of only 9%. It is the fourth leading cause of cancer-related death in the United States. Treatment for pancreatic cancer typically involves a combination of surgery, chemotherapy, and radiation therapy. Surgery is the most common treatment, and is used to remove tumors and surrounding tissue. Chemotherapy and radiation therapy are used to kill cancer cells that may remain after surgery. The oncology market for pancreatic cancer is highly competitive, with many companies developing new treatments and therapies. Companies are focusing on developing targeted therapies, immunotherapies, and combination therapies to improve outcomes for patients. Companies in the pancreatic cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more